GoI increases interval between Covishield doses to 12-16 weeks; says decision ‘science-based’
New Delhi: The Centre Thursday approved extending the gap between the two doses of the Covishield vaccine to 12-16 weeks ...
Read moreNew Delhi: The Centre Thursday approved extending the gap between the two doses of the Covishield vaccine to 12-16 weeks ...
Read moreChennai: A 40-year-old man who took part in the 'Covishield' vaccine trial here has alleged serious side effects, including a ...
Read moreNew Delhi: The Drugs Controller General of India (DCGI) has given nod to Serum Institute of India (SII) for conducting ...
Read moreNew Delhi: Serum Institute of India (SII) has partnered with ‘AstraZeneca’ for manufacturing the Oxford vaccine candidate for COVID-19. Serum ...
Read more